Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1

Li,Baimou; Mao,Xiaopeng; Wang,Hua; Su,Guanyu; Mo,Chengqiang; Cao,Kaiyuan; Qiu,Shaopeng

doi:10.3892/ol.2018.7975

Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1

Authors:
- Baimou Li
- Xiaopeng Mao
- Hua Wang
- Guanyu Su
- Chengqiang Mo
- Kaiyuan Cao
- Shaopeng Qiu
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China, Research Center for Clinical Laboratory Standard, Zhongshan Medical School, Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: February 7, 2018 https://doi.org/10.3892/ol.2018.7975
Pages: 5193-5200

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the associations between vasculogenic mimicry (VM) and zinc finger E-box binding homeobox 1 (ZEB1) in bladder cancer. VM structure and ZEB1 expression were analyzed by cluster of differentiation 34/periodic acid Schiff (PAS) double staining and immunohistochemical staining in 135 specimens from patients with bladder cancer, and a further 12 specimens from normal bladder tissues. Three-dimensional (3-D) culture was used to detect VM formation in the bladder transitional cancer cell lines UM-UC-3 and J82, and the immortalized human bladder epithelium cell line SV-HUC-1 in vitro. ZEB1 expression in these cell lines was compared by reverse transcription-quantitative polymerase chain reaction and western blot assays. In addition, small interfering RNA was used to inhibit ZEB1 in UM-UC-3 and J82 cells, followed by 3-D culturing of treated cell lines. As a result, VM was observed in 31.1% of specimens from bladder cancer tissues, and cases with high ZEB1 expression accounted for 60.0% of patients with bladder cancer. In addition, ZEB1 expression was closely associated with VM (r=0.189; P<0.05), and also increased as the grade and stage of the tumor developed. In an in vitro assay, UM-UC-3 and J82 cells exhibited VM formation, however, SV-HUC-1 did not. Furthermore, VM-forming cancer cell lines UM-UC-3 and J82 exhibited higher ZEB1 expression. Notably, VM formation was inhibited following knockdown of ZEB1. In conclusion, ZEB1 may be associated with VM in bladder cancer and serve an important role in the process of VM formation. However, its detailed mechanism requires further study.

View Figures

View References

1	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
3	Mayr R, Fritsche HM and Pycha A and Pycha A: Radical cystectomy and the implications of comorbidity. Expert Rev Anticancer Ther. 14:289–295. 2014. View Article : Google Scholar : PubMed/NCBI
4	Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
5	Ahmadi SA, Moinfar M, Gohari Moghaddam K and Bahadori M: Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med. 13:498–503. 2010.PubMed/NCBI
6	Ma JL, Han SX, Zhu Q, Zhao J, Zhang D, Wang L and Lv Y: Role of twist in vasculogenic mimicry formation in hypoxic hepatocellular carcinoma cells in vitro. Biochem Biophys Res Commun. 408:686–691. 2011. View Article : Google Scholar : PubMed/NCBI
7	Karroum A, Mirshahi P, Faussat AM, Therwath A, Mirshahi M and Hatmi M: Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions. Eur J Pharmacol. 685:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
8	Liu Z, Sun B, Qi L, Li H, Gao J and Leng X: Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition. Cancer Sci. 103:813–820. 2012. View Article : Google Scholar : PubMed/NCBI
9	Liu Q, Qiao L, Liang N, Xie J and Zhang J, Deng G, Luo H and Zhang J: The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med. 20:1761–1769. 2016. View Article : Google Scholar : PubMed/NCBI
10	Wang H, Lin H, Pan J, Mo C, Zhang F, Huang B, Wang Z, Chen X, Zhuang J, Wang D and Qiu S: Vasculogenic mimicry in prostate cancer: The roles of EphA2 and PI3K. J Cancer. 7:1114–1124. 2016. View Article : Google Scholar : PubMed/NCBI
11	Zhang P, Sun Y and Ma L: ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle. 14:481–487. 2015. View Article : Google Scholar : PubMed/NCBI
12	Chen H, Lu W, Huang C, Ding K, Xia D, Wu Y and Cai M: Prognostic significance of ZEB1 and ZEB2 in digestive cancers: A cohort-based analysis and secondary analysis. Oncotarget. 8:31435–31448. 2017.PubMed/NCBI
13	Hanrahan K, O'Neill A, Prencipe M, Bugler J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K and Watson RW: The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer. Mol Oncol. 11:251–265. 2017. View Article : Google Scholar : PubMed/NCBI
14	Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, et al: ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J Clin Invest. 126:3219–3235. 2016. View Article : Google Scholar : PubMed/NCBI
15	Wang W, Lin P, Sun B, Zhang S, Cai W, Han C, Li L, Lu H and Zhao X: Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma. Biomed Res Int. 2014:8039142014.PubMed/NCBI
16	Cao Z, Sun B, Zhao X, Zhang Y, Gu Q, Liang X, Dong X and Zhao N: The expression and functional significance of Runx2 in hepatocellular carcinoma: Its role in vasculogenic mimicry and epithelial-mesenchymal transition. Int J Mol Sci. 18:pii: E5002017. View Article : Google Scholar
17	Yang Z, Sun B, Li Y, Zhao X, Zhao X, Gu Q, An J, Dong X, Liu F and Wang Y: ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Exp Mol Pathol. 98:352–359. 2015. View Article : Google Scholar : PubMed/NCBI
18	Wu K, Fan J, Zhang L, Ning Z, Zeng J, Zhou J, Li L, Chen Y, Zhang T, Wang X, et al: PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Cell Signal. 24:2273–2282. 2012. View Article : Google Scholar : PubMed/NCBI
19	Mahdavinezhad A, Yadegarazari R, Mousavi-Bahar SH, Poorolajal J, Jafari M, Amirzargar MA, Effatpanah H and Saidijam M: Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue. Investig Clin Urol. 58:140–145. 2017. View Article : Google Scholar : PubMed/NCBI
20	Kenney PA, Wszolek MF, Rieger-Christ KM, Neto BS, Gould JJ, Harty NJ, Mosquera JM, Zeheb R, Loda M, Darling DS, et al: Novel ZEB1 expression in bladder tumorigenesis. BJU Int. 107:656–663. 2011. View Article : Google Scholar : PubMed/NCBI
21	Liu B, Miyake H, Nishikawa M and Fujisawa M: Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection. Urol Oncol. 33:110.e11–8. 2015. View Article : Google Scholar
22	Xu Y, Li Q, Li XY, Yang QY, Xu WW and Liu GL: Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis. J Exp Clin Cancer Res. 31:162012. View Article : Google Scholar : PubMed/NCBI
23	Yu L, Wu S, Zhou L, Song W and Wang D: Expressions of CD133 and CD82/KAI1 in bladder urothelial carcinoma and their correlation with vasculogenic mimicry. Nan Fang Yi Ke Da Xue Xue Bao. 33:1336–1340. 2013.(In Chinese). PubMed/NCBI
24	Zhou L, Chang Y, Xu L, Hoang ST, Liu Z, Fu Q, Lin Z and Xu J: Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy. Oncotarget. 7:76214–76223. 2016. View Article : Google Scholar : PubMed/NCBI
25	Wang X, Wu Q, Xu B, Wang P, Fan W, Cai Y, Gu X and Meng F: MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. FEBS J. 282:4376–4388. 2015. View Article : Google Scholar : PubMed/NCBI
26	LI H, Song S, Xu Y, Zhao J and Liu H: Knockdown of ZEB1 suppresses the formation of vasculogenic mimicry in breast cancer cell line MDA-MB-231 through downregulation of Flk-1. Minerva Med. 108:191–193. 2017.PubMed/NCBI